PPARG and type 2 diabetes mellitus: PPARδ is the less studied receptor of this group (75) while PPARα and PPARγ have been extensively investigated as therapeutic targets especially in metabolic diseases like type 2 diabetes (T2D) (68, 71, 78, 125, 126).